Bleeding risk assessment should be performed before initiating either medication class
For patients on GLP-1 medications in the UK, yes
A consensus report of a particular topic contains a comprehensive examination and is authored by an expert panel and represents the panels collective analysis, evaluation and opinion
Before considering any peptide-based treatment, its reasonable to ask: Is there credible clinical evidence supporting its use
Keywords: IGF-1, Laron syndrome, Hypophysectomy, Hypotrichosis, Androgenetic alopecia, Growth hormone deficiency Established Facts Insulin-like growth factor 1 (IGF-1) has been shown to affect follicular proliferation, tissue remodeling, and the hair growth cycle, as well as follicular differentiation, identifying IGF-1 signaling as an important mitogenic and morphogenetic regulator in hair follicle biology
For example, better outcomes can be achieved with a combination of the DPP-4 inhibitor and metformin or TZD pioglitazone, and insulin and metformin, glyburide, and pioglitazone (Cersosimo et al., 2018)